As of 2024-12-11, the Fair Value of SynAct Pharma AB (SYNACT.ST) is -18.71 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 10.92 SEK, the upside of SynAct Pharma AB is -271.38%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -23.96 | -26.55 | -69.30 | -99.20 | -215.81 | -86.97 |
| YoY growth | -2.19% | -10.82% | -161.02% | -43.14% | -117.54% | -66.94% |
| Market Cap (mil) | 450.96 |
| P/E | |
| Forward P/E |
| EPS | -3.74 |
| Avg earnings growth rate | -66.94% |
| TTM earnings | -154.57 |